Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Chubb
AstraZeneca
Harvard Business School
Julphar
Accenture
Mallinckrodt
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086399

« Back to Dashboard

NDA 086399 describes THEOLAIR, which is a drug marketed by 3M and Medicis and is included in six NDAs. Additional details are available on the THEOLAIR profile page.

The generic ingredient in THEOLAIR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086399
Tradename:THEOLAIR
Applicant:Medicis
Ingredient:theophylline
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength125MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fish and Richardson
Johnson and Johnson
US Department of Justice
Argus Health
Julphar
Express Scripts
US Army
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.